Before a new liver cancer treatment is introduced, clinical trials are performed to see how the treatment compares to current options. For instance, researchers may compare a new chemotherapy drug to a drug that is commonly prescribed for liver cancer, helping to determine if the new medication can more effectively treat the condition or reduce the number of side effects that patients experience.
The clinical trials process is important not only for introducing new treatment options, but also for determining how to use those options most effectively. For instance, trials may study how a specific treatment affects people with different types and stages of liver cancer, allowing oncologists to more successfully individualize each patient’s treatment in the future.
Where are clinical trials performed?
Not all cancer centers offer clinical trials. Moffitt Cancer Center, however, has been actively involved in liver cancer research for several decades. We are the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida – a designation that recognizes our longstanding commitment to scientific leadership.
At Moffitt, our clinical trials have produced many significant advances in liver cancer treatment. We have studied a variety of biologic therapies, surgical techniques, chemotherapy drugs and radiation delivery methods that have directly improved patient outcomes. In many cases, these advances have become the "gold standard" for liver cancer treatment in all settings – but our patients were able to access them first.
To learn more about our liver cancer clinical trials, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. Our clinical trial navigators can help you explore our current trials and determine if any are right for your specific needs. You do not need a physician’s referral to seek treatment at Moffitt.